Krystal Biotech, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Krystal Biotech, Inc. (KRYS) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$210.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-07
- Krystal Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$159.00K.
- Krystal Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$7.00K.
- Krystal Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$9.00K.
- Krystal Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$210.00K.
- Krystal Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$15.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$210.00K 10-K · filed 2018-03-12 | ||
| 2017-09-30 | -$51.00K 10-Q · filed 2017-11-13 | |||
| 2017-03-31 | -$7.00K 10-Q · filed 2018-05-07 | -$16.00K derived: sum of 2 quarters · filed 2018-05-07 | ||
| 2016-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$15.00K 10-K · filed 2018-03-12 | ||
| 2016-09-30 | -$6.00K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |